Investor Auctus Fund Management Llc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Auctus Fund Management Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-08-14 13G/A BRTX / BioRestorative Therapies, Inc. 759,087 784,655
2025-05-15 13G/A BRTX / BioRestorative Therapies, Inc. 692,418 759,087
2024-11-14 13G/A BRTX / BioRestorative Therapies, Inc. 482,315 692,418
2024-11-14 13G/A GTHP / Guided Therapeutics, Inc. 5,328,840 5,804,865
2024-02-14 13G/A GTHP / Guided Therapeutics, Inc. 4,945,797 5,328,840
2024-02-14 13G/A BRTX / BioRestorative Therapies, Inc. 376,004 482,315
2024-02-14 13G/A UUU / Universal Safety Products, Inc 200,000 0
2023-02-14 13G/A BRTX / BioRestorative Therapies, Inc. 210,000 376,004
2023-02-14 13G/A GTHP / Guided Therapeutics, Inc. 4,755,098 4,945,797
2023-02-14 13G/A UUU / Universal Safety Products, Inc 200,000 200,000
2022-10-24 13G GTHP / Guided Therapeutics, Inc. 50,000 4,755,098
2022-07-14 13G BRTX / BioRestorative Therapies, Inc. 210,000
2022-03-11 13G UUU / Universal Safety Products, Inc 200,000
2017-03-09 13G GTHP / Guided Therapeutics, Inc. 50,000